Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia - PubMed (original) (raw)
Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia
A Kawamoto et al. Circulation. 2001.
Abstract
Background: We investigated the therapeutic potential of ex vivo expanded endothelial progenitor cells (EPCs) for myocardial neovascularization.
Methods and results: Peripheral blood mononuclear cells obtained from healthy human adults were cultured in EPC medium and harvested 7 days later. Myocardial ischemia was induced by ligating the left anterior descending coronary artery in male Hsd:RH-rnu (athymic nude) rats. A total of 10(6) EPCs labeled with 1,1'-dioctadecyl-1 to 3,3,3',3'-tetramethylindocarbocyanine perchlorate were injected intravenously 3 hours after the induction of myocardial ischemia. Seven days later, fluorescence-conjugated Bandeiraea simplicifolia lectin I was administered intravenously, and the rats were immediately killed. Fluorescence microscopy revealed that transplanted EPCs accumulated in the ischemic area and incorporated into foci of myocardial neovascularization. To determine the impact on left ventricular function, 5 rats (EPC group) were injected intravenously with 10(6) EPCs 3 hours after ischemia; 5 other rats (control group) received culture media. Echocardiography, performed just before and 28 days after ischemia, disclosed ventricular dimensions that were significantly smaller and fractional shortening that was significantly greater in the EPC group than in the control group by day 28. Regional wall motion was better preserved in the EPC group. After euthanization on day 28, necropsy examination disclosed that capillary density was significantly greater in the EPC group than in the control group. Moreover, the extent of left ventricular scarring was significantly less in rats receiving EPCs than in controls. Immunohistochemistry revealed capillaries that were positive for human-specific endothelial cells.
Conclusions: Ex vivo expanded EPCs incorporate into foci of myocardial neovascularization and have a favorable impact on the preservation of left ventricular function.
Similar articles
- Endothelial progenitor cells delivered into the pericardial space incorporate into areas of ischemic myocardium.
Saltzman AJ, Choi SW, Dabreo A, Baur WE, Weiss E, Nguyen K, Ishibashi F, Celestin FF, Karia DH, Pandian NG, Karas RH, Waxman S. Saltzman AJ, et al. Cardiovasc Revasc Med. 2010 Oct-Dec;11(4):241-8. doi: 10.1016/j.carrev.2009.06.003. Cardiovasc Revasc Med. 2010. PMID: 20934657 - Implantation of endothelial progenitor cells into laser-induced channels in rat ischemia hindlimb augments neovascularization.
Liu C, Sun Z, Du X, Chen X, Feng J, Jia B. Liu C, et al. Ann Vasc Surg. 2005 Mar;19(2):241-7. doi: 10.1007/s10016-004-0173-8. Ann Vasc Surg. 2005. PMID: 15782270 - Transplantation of endothelial progenitor cells for therapeutic neovascularization.
Kawamoto A, Asahara T, Losordo DW. Kawamoto A, et al. Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):221-5. doi: 10.1016/s1522-1865(03)00082-9. Cardiovasc Radiat Med. 2002. PMID: 12974378 Review. - Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia.
Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T. Kawamoto A, et al. Circulation. 2003 Jan 28;107(3):461-8. doi: 10.1161/01.cir.0000046450.89986.50. Circulation. 2003. PMID: 12551872 - Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors.
Murohara T. Murohara T. Trends Cardiovasc Med. 2001 Nov;11(8):303-7. doi: 10.1016/s1050-1738(01)00128-1. Trends Cardiovasc Med. 2001. PMID: 11728877 Review.
Cited by
- Navigating the Landscape of Coronary Microvascular Research: Trends, Triumphs, and Challenges Ahead.
Wang Y, Wang B, Ling H, Li Y, Fu S, Xu M, Li B, Liu X, Wang Q, Li A, Zhang X, Liu M. Wang Y, et al. Rev Cardiovasc Med. 2024 Aug 16;25(8):288. doi: 10.31083/j.rcm2508288. eCollection 2024 Aug. Rev Cardiovasc Med. 2024. PMID: 39228508 Free PMC article. Review. - Bone marrow cells contribute to seven different endothelial cell populations in the heart.
Shabani P, Ohanyan V, Alghadeer A, Gavazzi D, Dong F, Yin L, Kolz C, Shockling L, Enrick M, Zhang P, Shi X, Chilian W. Shabani P, et al. Basic Res Cardiol. 2024 Aug;119(4):699-715. doi: 10.1007/s00395-024-01065-x. Epub 2024 Jul 4. Basic Res Cardiol. 2024. PMID: 38963562 Free PMC article. - Endothelial progenitor cells for diabetic cardiac and kidney disease.
Raleigh MJ, Pasricha SV, Nauth A, Ward MR, Connelly KA. Raleigh MJ, et al. Stem Cells Transl Med. 2024 Jul 15;13(7):625-636. doi: 10.1093/stcltm/szae025. Stem Cells Transl Med. 2024. PMID: 38733609 Free PMC article. Review. - Cell Therapy in the Treatment of Coronary Heart Disease.
Chepeleva EV. Chepeleva EV. Int J Mol Sci. 2023 Nov 28;24(23):16844. doi: 10.3390/ijms242316844. Int J Mol Sci. 2023. PMID: 38069167 Free PMC article. Review. - Cellular and molecular mechanisms in vascular repair after traumatic brain injury: a narrative review.
Zhao ZA, Yan L, Wen J, Satyanarayanan SK, Yu F, Lu J, Liu YU, Su H. Zhao ZA, et al. Burns Trauma. 2023 Sep 4;11:tkad033. doi: 10.1093/burnst/tkad033. eCollection 2023. Burns Trauma. 2023. PMID: 37675267 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical